Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: a controlled double-blind trial.

Ihle, B U; Whitworth, J A; Shahinfar, S; Cnaan, A; Kincaid-Smith, P S; Becker, G J

Ihle, B U; Whitworth, J A; Shahinfar, S; Cnaan, A; Kincaid-Smith, P S; Becker, G J.

Affiliation

Ihle BU; Department of nephrology, The Royal Melbourne Hospital, Victoria, Australia.

Am J Kidney Dis ; 27(4): 489-95, 1996 Apr.

Article in En | MEDLINE | ID: mdl-8678058

Subject(s)

Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Enalapril/therapeutic use; Kidney Failure, Chronic/drug therapy; Adolescent; Adult; Aged; Blood Pressure/drug effects; Disease Progression; Double-Blind Method; Female; Glomerular Filtration Rate/drug effects; Humans; Kidney Failure, Chronic/physiopathology; Linear Models; Male; Middle Aged; Placebos; Prospective Studies; Statistics, Nonparametric

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Angiotensin-Converting Enzyme Inhibitors / Enalapril / Kidney Failure, Chronic Type of study: Clinical_trials / Guideline / Observational_studies Language: En Journal: Am J Kidney Dis Year: 1996 Type: Article Affiliation country: Australia

Search on Google

Add to My VHL

XML

PubMed Links